This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1989-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989-1990
Title: Werner Schiestl: Innovator in Pharmaceutical Chemistry
Introduction
Werner Schiestl is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on imidazolium salts. With a total of 2 patents to his name, Schiestl's inventions have valuable applications in medicine.
Latest Patents
Schiestl's latest patents include the development of 1,3-disubstituted imidazolium salts. These compounds possess valuable pharmacological properties, including antibacterial, antimycotic, protozoacidal, and anthelmintic effects. They are especially effective against parasitic protozoa and worms. The compounds can be synthesized using known methods, showcasing their potential for pharmaceutical applications.
Career Highlights
Werner Schiestl is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has contributed to advancements in drug development and has the potential to improve treatment options for various infections and diseases.
Collaborations
Schiestl has collaborated with notable colleagues, including Wilhelm Klotzer and Helmut Link. These partnerships have fostered innovation and have played a crucial role in the development of his patented compounds.
Conclusion
Werner Schiestl's contributions to pharmaceutical chemistry through his patents on imidazolium salts highlight his role as an influential inventor. His work continues to impact the field and offers promising avenues for future research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile